Impact of Extensive Drug Resistance on Treatment Outcomes in Non-HIV-Infected Patients with Multidrug-Resistant Tuberculosis
Open Access
- 15 November 2007
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (10) , 1290-1295
- https://doi.org/10.1086/522537
Abstract
Background. Recently, serious concerns about extensively drug-resistant tuberculosis (XDR-TB), which shows resistance to second-line anti-TB drugs inKeywords
This publication has 19 references indexed in Scilit:
- Extensively Drug-Resistant Tuberculosis: Are We Learning from History or Repeating It?Clinical Infectious Diseases, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaPublished by Elsevier ,2006
- Cost of treatment for multidrug‐resistant tuberculosis in South KoreaRespirology, 2006
- Prognostic factors for surgical resection in patients with multidrug-resistant tuberculosisEuropean Respiratory Journal, 2006
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Worldwide Incidence of Multidrug‐Resistant TuberculosisThe Journal of Infectious Diseases, 2002
- Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosisEuropean Journal of Cardio-Thoracic Surgery, 1999
- Epidemiology of HIV infection in the Republic of KoreaJournal of Korean Medical Science, 1999
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Treatment of 171 Patients with Pulmonary Tuberculosis Resistant to Isoniazid and RifampinNew England Journal of Medicine, 1993